publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,fulltext,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,100.0
1528,PRECIS-2,Effectiveness was initially defined as the change in EQ-5D scores and a cost-effectiveness analysis was performed using this outcome measure.,fulltext,Effectiveness was initially defined as the change in EQ-5D scores and a cost-effectiveness analysis was performed using this outcome measure.,100.0
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, 8 thus confirming they had low mood.",100.0
1528,PRECIS-2,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,fulltext,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,100.0
1528,PRECIS-2,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,fulltext,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,100.0
1528,PRECIS-2,Participants allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,fulltext,se allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,91.26984126984127
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,The incremental costs effectiveness ratio was calculated by dividing the mean reduction in costs between intervention and control (−£401) by the mean reduction in BDI score (−3.41).,fulltext,The incremental costs effectiveness ratio was calculated by dividing the mean reduction in costs between intervention and control (−£401) by the mean reduction in BDI score (−3.41).,100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1529,PRECIS-2,This clinical trial was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,fulltext,This clinical trial was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,100.0
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",100.0
1529,PRECIS-2,"After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",fulltext,"After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",100.0
1529,PRECIS-2,"At the end of each session, the participants were asked to run through certain drills empirically outside research environment.",fulltext,"At the end of each session, the participants were asked to run through certain drills empirically outside research environment.",100.0
1529,PRECIS-2,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",fulltext,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 131 fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).",100.0
1529,PRECIS-2,"This study was conducted to investigate the effect of Fordyce Happiness Model (FHM) on depression, stress, anxiety, and fatigue in MS patients.",fulltext,"This study was conducted to investigate the effect of Fordyce Happiness Model (FHM) on depression, stress, anxiety, and fatigue in MS patients.",100.0
1529,PRECIS-2,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",fulltext,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1567,PRECIS-2,The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS in a multi-site trial with persons with MS.,fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",99.46808510638297
1567,PRECIS-2,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,fulltext,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,100.0
1567,PRECIS-2,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months post-intervention.",fulltext,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months postintervention.",99.5049504950495
1567,PRECIS-2,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving).",fulltext,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving).",100.0
1567,PRECIS-2,A repeated measures ANOVA (RM-ANOVA) design was utilized to determine time and time by group effects on performance and self-report outcomes.,fulltext,A repeated measures ANOVA (RM-ANOVA) design was utilized to determine time and time by group effects on performance and self-report outcomes.,100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.,fulltext,The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.,100.0
1567,PRECIS-2,"Overall, participation in the intervention was high. The mean number of classes attended was 6.4 (SD ¼ 2.3, range 0e8) for those randomized to the MAPSS-MS group.",fulltext,"Overall, participation in the intervention was high. The mean number of classes attended was 6.4 (SD ¼ 2.3, range 0e8) for those randomized to the MAPSS-MS group.",100.0
1567,PRECIS-2,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8week MAPSS-MS intervention or usual care plus freely available computer games.,99.40119760479041
1567,PRECIS-2,The small group-based intervention and the 6 months of follow-up testing were delivered to 10 cohorts of participants across the three sites over a 34-month period.,fulltext,The small group-based intervention and the 6 months of followup testing were delivered to 10 cohorts of participants across the three sites over a 34-month period.,99.39024390243902
1568,PRECIS-2,Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment.,fulltext,Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment.,100.0
1568,PRECIS-2,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",fulltext,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",100.0
1568,PRECIS-2,"The aim of the present study was therefore to investigate the efficacy of supervised exercise therapy in newly diagnosed patients (⩽2 years since diagnosis) on primarily relapse rate and global brain atrophy and secondarily on regional brain atrophy, lesion load and diffusion-kurtosis MRI-measures of microstructural integrity.",fulltext,"The aim of the present study was therefore to investigate the efficacy of supervised exercise therapy in newly diagnosed patients (⩽2 years since diagnosis) on primarily relapse rate and global brain atrophy and secondarily on regional brain atrophy, lesion load and diffusion-kurtosis MRI-measures of microstructural integrity.",100.0
1568,PRECIS-2,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",fulltext,"the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",100.0
1568,PRECIS-2,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",fulltext,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",100.0
1568,PRECIS-2,Patients gave informed written consent prior to inclusion.,fulltext,Patients gave informed written consent prior to inclusion.,100.0
1568,PRECIS-2,The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,fulltext,The present study is a national multicentre singleblinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,99.57983193277312
1568,PRECIS-2,"Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",fulltext,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",100.0
1569,PRECIS-2,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",fulltext,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",100.0
1569,PRECIS-2,"At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1.",fulltext,"At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1.",100.0
1569,PRECIS-2,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",fulltext,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",100.0
1569,PRECIS-2,A mean adherence of 6.2 out of 10 was reported for the home-based TOCT program.,fulltext,A mean adherence of 6.2 out of 10 was reported for the home-based TOCT program.,100.0
1569,PRECIS-2,"Phase 1 was composed of six gait-based workstations and treadmill training, whereas Phase 2 was based on progressive task-oriented tasks practice at home with monthly visits to adjust activities levels.",fulltext,"Phase 1 was composed of six gait-based workstations and treadmill training, whereas Phase 2 was based on progressive task-oriented tasks practice at home with monthly visits to adjust activities levels.",100.0
1569,PRECIS-2,Eligible patients have been randomized to 10 supervised TOCT sessions over two weeks (Phase 1) followed by a 12-weeks home-based task-oriented program (Phase 2) or a delayed-treatment group.,fulltext, have been randomly assigned to 10 supervised TOCT sessions over two weeks (Phase 1) followed by a 12-weeks home-based task-oriented program (Phase 2) or a delayed-treatment group.,90.52631578947368
1569,PRECIS-2,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,fulltext,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,100.0
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1569,PRECIS-2,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",fulltext," The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program",99.6078431372549
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006.",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 20",95.1219512195122
1570,PRECIS-2,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",fulltext,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",100.0
1570,PRECIS-2,"For comparison of the primary and final EDSS in each group, the relapse rate between the groups and side effects between the drugs, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",fulltext,"For comparison of the primary and final EDSS in each group, the relapse rate between the groups and side effects between the drugs, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",100.0
1570,PRECIS-2,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10 9 / L , platelet count ≤ 100 x 10 9 / L , neutrophil count ≤ 1.5 x 10 9 / L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β- interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow up period.",fulltext," than 6. Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10 9 / L , platelet count ≤ 100 x 10 9 / L , neutrophil count ≤ 1.5 x 10 9 / L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with βinterferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow ",99.00990099009901
1570,PRECIS-2,Ninety patients referring to Farshchian Hospital were entered in this study.,fulltext,Ninety patients referring to Farshchian Hospital were entered in this study.,100.0
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1570,PRECIS-2,Comparison of the average primary and final EDSS using the paired samples t.test showed a significant statistical difference (P < 0.05).,fulltext,Comparison of the average primary and final EDSS using the paired samples t.test showed a significant statistical difference (P < 0.05).,100.0
1769,PRECIS-2,The dose of corticotrophin was adjusted to produce just enough,fulltext,The dose of corticotrophin was adjusted to produce just enough,100.0
1769,PRECIS-2,Patients with multiple sclerosis were randomly selected into treated and control groups.,fulltext,Patients with multiple sclerosis were randomly selected into treated and control groups;,100.0
1769,PRECIS-2,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,PRECIS-2,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,100.0
1769,PRECIS-2,of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,fulltext,of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,100.0
1769,PRECIS-2,"This controlled study was started in 1963 in three cities- Belfast, Leeds, and Manchester.",fulltext,"This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.",97.77777777777777
1769,PRECIS-2,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",fulltext,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.",100.0
1769,PRECIS-2,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,100.0
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1770,PRECIS-2,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Mann-Whitney U tests revealed a statistically significant greater improvement in the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.",fulltext,"n. Whitney U tests revealed a statistically significant greater improvementin the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.",98.33333333333333
1770,PRECIS-2,Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged.,fulltext,Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged.,100.0
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme.",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme ",100.0
1770,PRECIS-2,"Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",69.87179487179486
1770,PRECIS-2,"The overall impression scores, both by the patient and the doctor, and the EDSS were comparable at any assessment in both treatment groups.",fulltext,"The overall impression scores, both by the patient and the doctor, and the EDSS were comparable at any assesment in both treatment groups.",99.28057553956835
1770,PRECIS-2,"Patients were withdrawn from the study if other treatment with ACTH, corticosteroids or immunosuppressive drugs was started.",fulltext,"Patients were withdrawn from the study if other treatment with ACTH, corticosteroids or immunosuppressive drugs was started.",100.0
1771,PRECIS-2,"Study limitations include that despite being a long-term exercise study, cognitive performance was a secondary outcome (the main RCT was powered toward brain volumetric changes), and thus, the present study merely classifies as a pilot/explorative study in regard to cognitive performance outcomes.",fulltext,"6 Study limitations include that despite being a longterm exercise study, cognitive performance was a secondary outcome (the main RCT was powered toward brain volumetric changes), and thus, the present study merely classifies as a pilot/explorative study in regard to cognitive performance outcome",98.99328859060402
1771,PRECIS-2,This was a 24-week randomized controlled cross-over trial.,fulltext,This was a 24-week randomized controlled cross-over trial.,100.0
1771,PRECIS-2,"Despite great medical advances that have resulted in several available disease-modifying treatments, no approved pharmacological treatment specific for cognitive impairment in MS exists.",fulltext,"Despite great medical advances that have resulted in several available disease-modifying treatments, no approved pharmacological treatment specific for cognitive impairment in MS exists.",100.0
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",100.0
1771,PRECIS-2,"To our knowledge, this is the first study to investigate cognitive performance outcomes in pwMS in a longitudinal RCT following 24 weeks of supervised high-intensity PAE intervention.",fulltext," To our knowledge, this is the first study to investigate cognitive performance outcomes in pwMS in a longitudinal RCT following 24 weeks of supervised highintensity PAE intervention",98.90710382513662
1771,PRECIS-2,"The PAE group underwent supervised high-intensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) without commencing PAE.",fulltext,"The PAE group underwent supervised highintensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) without commencing PAE.",99.48717948717949
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",100.0
1771,PRECIS-2,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test).",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO 2 -max test).",100.0
1771,PRECIS-2,All longitudi nal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat lin ear mixed effects model with time and group as the fac tors of interest.,fulltext,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,98.49246231155779
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1772,PRECIS-2,Patients were randomized 3:1 to switch to fingolimod or remain on iDMT for 6 months with no intervening washout period.,fulltext,"Patients were randomized 3:1 to switch to fingolimod (FTY720; Gilenya®, Novartis Pharma AG, Basel, Switzerland) 0.5 mg or remain on/switch to an iDMT for 6 months with no intervening washout period.",100.0
1772,PRECIS-2,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",fulltext,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",100.0
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study. Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.",fulltext,"a Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) Calkwood et al. BMC Neurology 2014, 14:220 Page 2 of 11 http://www.biomedcentral.com/1471-2377/14/220 score of 0–5.5 were eligible to participate in the study. Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy chang",99.49367088607595
1772,PRECIS-2,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,PRECIS-2,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",100.0
1772,PRECIS-2,All outcomes were evaluated after 6 months of treatment.,fulltext,All outcomes were evaluated after 6 months of treatment.,100.0
1772,PRECIS-2,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months.,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 month,98.94736842105263
1772,PRECIS-2,"Study enrollment was completed in October 2011. Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDMT.",fulltext,"s Study enrollment was completed in October 2011. Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDM",98.79518072289156
1772,PRECIS-2,Missing data were imputed using the last observation carried forward.,fulltext,. Missing data were imputed using the last observation carried forwar,97.10144927536231
1773,PRECIS-2,Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,fulltext,Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,100.0
1773,PRECIS-2,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",fulltext,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",100.0
1773,PRECIS-2,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH ® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",fulltext,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH ® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",100.0
1773,PRECIS-2,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
1773,PRECIS-2,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180◦) and to lower the load (eccentric action; 180–90◦) in a controlled manner.,fulltext,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180 ◦ ) and to lower the load (eccentric action; 180–90 ◦ ) in a controlled manner.,100.0
1773,PRECIS-2,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated with the intervention, a formal invitation to take part in the study was offered.",fulltext,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",99.11764705882354
1773,PRECIS-2,"Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study. After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated with the intervention, a formal invitation to take part in the study was offered. The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",fulltext,"Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study. All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered. The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, accord C. Medina-Perez et al. / Effects of a RTP and subsequent detraining on muscle strength and muscle power in MS patients 525 Table 1 Demographic data at baseline Exercise group Control group P-values (n = 30) (n = 12) Age (yr) 49.6 ± 11.0 46.2 ± 7.5 0.395 Weight (Kg) 68.1 ± 11.4 63.3 ± 12.0 0.177 Height (cm) 165.0 ± 8.3 162.8 ± 6.0 0.485 BMI (Kg/m 2 ) 25.0 ± 4.1 24.0 ± 4.9 0.200 EDSS 4.5 ± 2.1 4.1 ± 0.5 0.380 Time since diagnosis (yr) 11.3 ± 6.1 12.2 ± 4.5 0.570 Data are given as mean ± SD. P-values: EG vs. CG at baseline. EDSS: Expanded Disability Status Scale. ing to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",99.5016611295681
1773,PRECIS-2,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average muscle power and muscle endurance.",fulltext,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, aver",71.85185185185186
648,PRECIS-2,"For the analysis of maternal outcomes, women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received.",fulltext,"For the analysis of maternal outcomes, women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received.",100.0
648,PRECIS-2,Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.,fulltext,Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.,100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",100.0
648,PRECIS-2,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",100.0
648,PRECIS-2,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",fulltext,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",100.0
648,PRECIS-2,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",fulltext,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",100.0
648,PRECIS-2,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",fulltext,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",100.0
648,PRECIS-2,Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision.,fulltext,Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision.,100.0
648,PRECIS-2,"If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).",fulltext,"If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).",100.0
648,PRECIS-2,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",fulltext,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",100.0
648,PRECIS-2,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,fulltext,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,100.0
648,PRECIS-2,"Compliance with all the allocated interventions was high, 87% overall.",fulltext,"Compliance with all the allocated interventions was high, 87% overall.",100.0
650,PRECIS-2,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,fulltext,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,fulltext,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,100.0
650,PRECIS-2,A regional care group in the Netherlands consisting of 77 family practices.,fulltext,A regional care group in the Netherlands consisting of 77 family practices.,100.0
650,PRECIS-2,Patients with score DFT >4 and DS >3 were eligible for trial participation.,fulltext,Patients with score DFT >4 and DS >3 were eligible for trial participation.,100.0
650,PRECIS-2,Multilevel analyses showed no significant differences in outcomes between the intervention and control arms.,fulltext,Multilevel analyses showed no significant differences in outcomes between the intervention and control arms.,100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
651,PRECIS-2,"After the screening visit (week –2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",fulltext,"After the screening visit (week –2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",100.0
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"The two trials, which were conducted at 53 primary care practices in the United Kingdom",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom",100.0
651,PRECIS-2,The primary outcome measure was the MiniAQLQ score.,fulltext,The primary outcome measure was the MiniAQLQ score.,100.0
651,PRECIS-2,"If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",fulltext,"If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",100.0
651,PRECIS-2,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,fulltext,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,100.0
651,PRECIS-2,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",100.0
651,PRECIS-2,We determined adherence on the basis of prescriptions issued versus prescribing instructions for patients with at least 6 months without a change in therapy.,fulltext,We determined adherence on the basis of prescriptions issued versus prescribing instructions for patients with at least 6 months without a change in therapy.,100.0
655,PRECIS-2,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",fulltext,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session ",100.0
655,PRECIS-2,All patients were analyzed in the group to which they were randomized.,fulltext,All patients were analyzed in the group to which they were randomized.,100.0
655,PRECIS-2,"A patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",fulltext," patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",99.45945945945947
655,PRECIS-2,All patients gave written informed consent.,fulltext,All patients gave written informed consent.,100.0
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
655,PRECIS-2,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",100.0
655,PRECIS-2,"The objective of this study was, therefore, to determine whether a maintenance TelePR carried out after an intensive initial PR programme was superior to usual care in sustaining, over time, the benefits achieved by the intensive PR.",fulltext,"The objective of this study was, therefore, to determine whether a maintenance TelePR carried out after an intensive initial PR programme was superior to usual care in sustaining, over time, the benefits achieved by the intensive PR.",100.0
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines 9 and having been clinically stable for the previous 4 weeks ",100.0
657,PRECIS-2,"The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",fulltext,"The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",100.0
657,PRECIS-2,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria 27 ; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,PRECIS-2,"The objective of this study was to compare the immediate and long-term effects of a 6-week individualized, group-based, comprehensive core stability intervention (GroupCoreDIST) with standard care on balance and trunk control in individuals with MS.",fulltext,"The objective of this study was to compare the immediate and long-term effects of a 6-week individualized, group-based, comprehensive core stability intervention (GroupCoreDIST) with standard care on balance and trunk control in individuals with MS.",100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,100.0
657,PRECIS-2,The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,fulltext,The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,100.0
657,PRECIS-2,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",fulltext,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care for individuals with MS in the same municipalities.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care for individuals with MS in the same municipalities.,100.0
657,PRECIS-2,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance.",fulltext,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance.",100.0
657,PRECIS-2,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
662,PRECIS-2,We recruited 40 participants across the UK. A pilot trial of at least 30 participants is adequate for obtaining estimates of the standard deviation of the outcome variable to determine sample size for an efficacy trial.,fulltext,We recruited 40 participants across the UK. A pilot trial of at least 30 participants is adequate for obtaining estimates of the standard deviation of the outcome variable to determine sample size for an efficacy trial.,100.0
662,PRECIS-2,"Outcome analysis was conducted using Stata 12.1. To compare group demographic and clinical characteristics at baseline, we used a binomial test for equal proportions between groups for categorical variables and an independent t-test for equal means between groups for continuous variables.",fulltext,"Outcome analysis was conducted using Stata 12.1. To compare group demographic and clinical characteristics at baseline, we used a binomial test for equal proportions between groups for categorical variables and an independent t-test for equal means between groups for continuous variables.",100.0
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,fulltext,All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,100.0
662,PRECIS-2,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",fulltext,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",100.0
662,PRECIS-2,"The primary outcome was distress, as measured by GHQ.",fulltext," distress, as measured by GHQ,",56.60377358490566
662,PRECIS-2,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",fulltext,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",100.0
662,PRECIS-2,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) 19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).",100.0
663,PRECIS-2,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON.,fulltext,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON.,100.0
663,PRECIS-2,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,PRECIS-2,PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week).,fulltext,PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week).,100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,The primary outcomes were walking speed assessed by the T25FW and complex walking assessed by the SSST.,fulltext,The primary outcomes were walking speed assessed by the T25FW 20 and complex walking assessed by the SSST.,100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",100.0
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
663,PRECIS-2,"This study was designed as a multi-centered, randomized control trial with two intervention groups and a control group (CON).",fulltext,"This study was designed as a multi-centered, randomized control trial with two intervention groups and a control group (CON).",100.0
663,PRECIS-2,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,The BMCT intervention was developed based on previously published programs and according to principle of the task-oriented approach.,fulltext,"The BMCT intervention was developed based on previously published programs 5,11,18,19 and according to principle of the task-oriented approach,",100.0
663,PRECIS-2,A total of 75% completed more than 15 out of the 20 sessions.,fulltext,A total of 75% completed more than 15 out of the 20 sessions.,100.0
664,PRECIS-2,"The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS). Strength training was undertaken by 48 of 60 participants in the intervention group and typically involved two to six different resistance exercises (e.g. wall press-ups, arm-curls, leg abduction, wall squats and/or regular squats, knee extensions, calf raises, sit-to-stand) each session.",fulltext,"The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS). Strength training was undertaken by 48 of 60 participants in the intervention group and typically involved two to six different resistance exercises (e.g. wall press-ups, arm-curls, leg abduction, wall squats and/or regular squats, knee extensions, calf raises, sit-to-stand) each session.",100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",100.0
664,PRECIS-2,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,PRECIS-2,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,PRECIS-2,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,fulltext,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,100.0
664,PRECIS-2,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions).",fulltext,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions).",100.0
664,PRECIS-2,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
665,PRECIS-2,"After consent, we randomised participants either to CCBT using ‘Beating the Blues’ ® (Ultrasis Ltd) or to usual care.",fulltext,"After consent, we randomised participants either to CCBT using ‘Beating the Blues’ ® (Ultrasis Ltd) or to usual care ",100.0
665,PRECIS-2,Participants expressed concern about the face validity of the Beck Depression Inventory II for the measurement of self-reported depression in people with MS.,fulltext,Participants expressed concern about the face validity of the Beck Depression Inventory II for the measurement of self-reported depression in people with MS.,100.0
665,PRECIS-2,"In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input.",fulltext,"In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input.",100.0
665,PRECIS-2,"Clinical outcomes included the Beck Depression Inventory (BDI-II) and Multiple Sclerosis Impact Scale (MSIS-29) at baseline, 8 and 21 weeks.",fulltext,"Clinical outcomes included the Beck Depression Inventory (BDI-II) and Multiple Sclerosis Impact Scale (MSIS-29) at baseline, 8 and 21 weeks.",100.0
665,PRECIS-2,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",fulltext,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",100.0
665,PRECIS-2,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,fulltext,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,100.0
665,PRECIS-2,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",100.0
665,PRECIS-2,"Beating the Blues ® consists of eight computer-interactive sessions, of approximately 50 minutes each in duration, designed to be taken weekly.",fulltext,"Beating the Blues ® consists of eight computer-interactive sessions, of approximately 50 minutes each in duration, designed to be taken weekly.",100.0
665,PRECIS-2,Two participants in each arm were lost to follow-up at 21 weeks post-randomisation.,fulltext,Two participants in each arm were lost to follow-up at 21 weeks post-randomisation.,100.0
665,PRECIS-2,The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.,fulltext,The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.,100.0
665,PRECIS-2,"The recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial, was 4.1%.",fulltext,"The recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial, was 4.1%.",100.0
665,PRECIS-2,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
665,PRECIS-2,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
665,PRECIS-2,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring.",fulltext,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring ",100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",100.0
666,PRECIS-2,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,fulltext,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,100.0
666,PRECIS-2,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",fulltext,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",100.0
666,PRECIS-2,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment.",fulltext,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment.",100.0
666,PRECIS-2,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,fulltext,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,100.0
668,PRECIS-2,"Our results suggest that contrary to our predictions, PRT did not improve walking performance in adults with relapsing–remitting MS and mild to moderate walking difficulty.",fulltext,"Our results suggest that contrary to our predictions, PRT did not improve walking performance in adults with relapsing–remitting MS and mild to moderate walking di",94.76744186046511
668,PRECIS-2,Analysis was completed without Bonferroni adjustment because we decided that this would have resulted in a risk of missing real effects (type II errors) and the consequences of any type I errors would not lead to any negative effects on participants.,fulltext,Analysis was completed without Bonferroni adjustment because we decided that this would have resulted in a risk of missing real effects (type II errors) and the consequences of any type I errors would not lead to any negative effects on participants.,100.0
668,PRECIS-2,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis.",100.0
668,PRECIS-2,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers).",fulltext,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers).",100.0
668,PRECIS-2,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",fulltext,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",100.0
668,PRECIS-2,"People in the training program attended a mean of 18.4 (SD 2.9, range 6–20) of their 20 scheduled sessions, while people in the social program attended a mean of 6.2 (SD 3.1, range 0–10) of their 10 scheduled sessions.",fulltext,"People in the training program attended a mean of 18.4 (SD 2.9, range 6–20) of their 20 scheduled sessions, while people in the social program attended a mean of 6.2 (SD 3.1, range 0–10) of their 10 scheduled sessions.",100.0
668,PRECIS-2,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",fulltext,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic.",100.0
669,PRECIS-2,pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute.,fulltext,pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute.,100.0
669,PRECIS-2,The EXP group completed 607 of 648 prescribed sessions (94%).,fulltext,The EXP group completed 607 of 648 prescribed sessions (94%).,100.0
669,PRECIS-2,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",fulltext,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",100.0
669,PRECIS-2,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,fulltext,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,100.0
669,PRECIS-2,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,PRECIS-2,Patients were tested at two time points (0 and 12 weeks).,fulltext,Patients were tested at two time points (0 and 12 weeks).,100.0
669,PRECIS-2,The WLC group was offered a comparable training program after the final measurements.,fulltext, was offered a comparable training program after the final measurements.,84.70588235294117
669,PRECIS-2,Groups were compared by means of a linear mixed model analysis which accounts for fixed and random effects (participants). These models adjust for confounding variables and dropout. Intention-to-treat analysis was performed.,fulltext,Groups were compared by means of a linear mixed model analysis which accounts for fixed and random effects (participants). These models adjust for confounding variables and dropout. Intention-to-treat analysis was performed.,100.0
669,PRECIS-2,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",fulltext,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",100.0
669,PRECIS-2,"If a participant had been inactive, a phone call was made for enquiry.",fulltext,"If a participant had been inactive, a phone call was made for enquiry.",100.0
669,PRECIS-2,"Neural imaging was recorded at UZA (University Hospital Antwerp, in Wilrijk) on another day mostly within 1-week time period.",fulltext,"Neural imaging was recorded at UZA (University Hospital Antwerp, in Wilrijk) on another day mostly within 1-week time period.",100.0
669,PRECIS-2,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,fulltext,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,100.0
669,PRECIS-2,Adults with MS were included based on the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,100.0
669,PRECIS-2,Participants received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,S received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,94.6078431372549
669,PRECIS-2,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",fulltext,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",100.0
669,PRECIS-2,"Adults with multiple sclerosis were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",91.62303664921467
670,PRECIS-2,The intervention involved a series of weekly one hour therapeutic massage treatments conducted over eight weeks and a subsequent eight week follow up period.,fulltext,The intervention involved a series of weekly one hour therapeutic massage treatments conducted over eight weeks and a subsequent eight week follow up period.,100.0
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",fulltext,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",100.0
670,PRECIS-2,"The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",fulltext,"The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",100.0
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",100.0
670,PRECIS-2,All treatments were delivered by supervised student therapists in the final term of their two year massage therapy program.,fulltext,All treatments were delivered by supervised student therapists in the final term of their two year massage therapy program.,100.0
670,PRECIS-2,"Self-Efficacy [SE] was the outcome for the study, measured using the Multiple Sclerosis Self-Efficacy survey [MSSE].",fulltext,"Self-Efficacy [SE] was the outcome for the study, measured using the Multiple Sclerosis Self-Efficacy survey [MSSE].",100.0
670,PRECIS-2,"The research undertaken was a practical trial that investigated the effects of a pragmatic massage therapy treatment protocol using a prospective randomized pretest, posttest waitlist control design.",fulltext,"The research undertaken was a practical trial that investigated the effects of a pragmatic massage therapy treatment protocol using a prospective randomized pretest, posttest waitlist control design.",100.0
671,PRECIS-2,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",fulltext,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treat ment within the preced ing month, or participating in another clinical trial.",100.0
671,PRECIS-2,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population.",fulltext,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald’s criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,PRECIS-2,"At the end of the 20 week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",fulltext,"At the end of the 20 week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,"The study was fully funded by the National Institute of Health Research (Research for Patient Benefit Programme; PB-PG 1013–32047), UK.",fulltext,"The study was fully funded by the National Institute of Health Research (Research for Patient Benefit Programme; PB PG 1013–32047), UK.",100.0
671,PRECIS-2,The primary analysis population was defined as all participants who completed baseline and 36-week assessments.,fulltext,The primary analysis population was defined as all participants who completed baseline and 36 week assess ments.,100.0
671,PRECIS-2,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",fulltext,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",100.0
671,PRECIS-2,"Two thirds of the participants in the standing frame group continued to stand regularly in the frame during the 36 week period, which, in light of the literature, we consider to be a high proportion.",fulltext,"Two thirds of the participants in the standing frame group continued to stand regularly in the frame during the 36 week period, which, in light of the literature, we consider to be a high proportion.",100.0
671,PRECIS-2,"The intervention was delivered by physiotherapists working within the NHS, who did not undergo specific training for this intervention, making it likely that similar results would be gained on implementation within usual practice.",fulltext,"The intervention was delivered by physiotherapists working within the NHS, who did not undergo specific training for this intervention, making it likely that similar results would be gained on implementation within usual practice.",100.0
671,PRECIS-2,The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at the primary endpoint of 36 weeks post-randomisation.,fulltext,The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,100.0
671,PRECIS-2,"The use of the standing frame resulted in a significant increase in AMCA score compared with that for usual care alone, with a fully adjusted between-group difference in AMCA score at 36 weeks of 4·7 points (95% CI 1·9–7·5; p=0·0014).",fulltext,"The use of the standing frame resulted in a significant increase in AMCA score compared with that for usual care alone, with a fully adjusted between-group difference in AMCA score at 36 weeks of 4·7 points (95% CI 1·9–7·5; p=0·0014).",100.0
671,PRECIS-2,"Our CACE analysis showed that accounting for compliance to the intervention resulted in a larger estimated intervention effect, with the prespecified minimal clinically important difference of 9 points on the AMCA score contained within the 95% CIs of all six compliance definitions.",fulltext,"Our CACE analysis showed that accounting for compliance to the intervention resulted in a larger estim ated intervention effect, with the prespecified minimal clinically important difference of 9 points on the AMCA score contained within the 95% CIs of all six compliance definitions.",100.0
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the inter vention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements ",100.0
671,PRECIS-2,"After baseline assessment, participants were randomised (1:1) by computer-generated assignment to either a standing frame programme plus usual care or usual care alone.",fulltext,"After baseline assessment, participants were randomised (1:1) by computer-generated assignment to either a standing frame programme plus usual care or usual care alone.",100.0
673,PRECIS-2,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",99.48979591836735
673,PRECIS-2,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",fulltext,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",100.0
673,PRECIS-2,Treatment fidelity was optimised by the instructors and participants documenting programme adherence.,fulltext,Treatment fidelity was optimised by the instructors and participants documenting programme adherence.,100.0
673,PRECIS-2,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
673,PRECIS-2,"This trial took place from April 2008 to October 2009, in 10 regions across the Republic of Ireland.",fulltext,"This trial took place from April 2008 to October 2009, in 10 regions across the Republic of Ireland.",100.0
673,PRECIS-2,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions. Those in the control group were asked not to change of their exercise habits (n = 71). The primary outcome was the Multiple Sclerosis Impact Scale (MSIS) 29v2 physical component, measured before and after the 10-week intervention.",fulltext,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions. Those in the control group were asked not to change of their exercise habits (n = 71). The primary outcome was the Multiple Sclerosis Impact Scale (MSIS) 29v2 physical component, measured before and after the 10-week intervention.",100.0
673,PRECIS-2,All participants were analysed in the groups to which they were randomised.,fulltext,All participants were analysed in the groups to which they were randomised.,100.0
674,PRECIS-2,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",fulltext,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",100.0
674,PRECIS-2,"Alemtuzumab-treated patients were more likely than SC IFN-b-1a–treated patients to show improvement in EDSS scores (p , 0.0001) on all 7 functional systems.",fulltext,"Alemtuzumab-treated patients were more likely than SC IFN-b-1a–treated patients to show improvement in EDSS scores (p , 0.0001) on all 7 functional systems.",100.0
674,PRECIS-2,"Alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly)",fulltext,"Alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly)",100.0
674,PRECIS-2,All procedures were approved by local institutional ethics review boards of participating sites.,fulltext, All procedures were approved by local institutional ethics review boards of participating sites,98.95833333333334
674,PRECIS-2,"In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-b-1a 44 mg and alemtuzumab 12 mg, respectively.",fulltext,"In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-b-1a 44 mg and alemtuzumab 12 mg, respectively.",100.0
674,PRECIS-2,Kaplan-Meier analyses were used to estimate risk for 3-month CDI (post hoc analysis) and 6-month CDI and risk for achieving specific ($20% or $15%) MSFC improvement or worsening thresholds.,fulltext, Kaplan-Meier analyses were used to estimate risk for 3-month CDI (post hoc analysis) and 6-month CDI and risk for achieving specific ($20% or $15%) MSFC improvement or worsening thresholds,99.47089947089947
674,PRECIS-2,"The following CARE-MS II tertiary endpoints were assessed: time to CDI ($1.0-point EDSS decrease from baseline sustained for $3 or $6 months, in patients with baseline score $2.0); proportion worsened ($0.5-point increase), stable, or improved ($0.5-point decrease) from baseline EDSS.",fulltext,"The following CARE-MS II tertiary endpoints were assessed: time to CDI ($1.0-point EDSS decrease from baseline sustained for $3 or $6 months, in patients with baseline score $2.0); proportion worsened ($0.5-point increase), stable, or improved ($0.5-point decrease) from baseline EDSS.",100.0
674,PRECIS-2,"CARE-MS II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-b-1a (SC IFN-b-1a) 44 mg in patients with RRMS.",fulltext,"CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-b-1a (SC IFN-b-1a) 44 mg in patients with RRMS.",100.0
675,PRECIS-2,"The most pragmatic design approach to delivery flexibility would leave the details of how to implement the intervention up to providers, in other words, what happens in usual care.",prompt,"The most pragmatic design approach to delivery flexibility would leave the details of how to implement the intervention up to providers, in other words, what happens in usual care.",100.0
675,PRECIS-2,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",fulltext,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",100.0
675,PRECIS-2,MBI consisted of a structured 8-week program of mindfulness training.,fulltext,MBI consisted of a structured 8-week program of mindfulness training.,100.0
675,PRECIS-2,Intention-to-treat analyses are reported.,fulltext,Intention-to-treat analyses are reported.,100.0
675,PRECIS-2,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59 –5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",fulltext,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59 –5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",100.0
675,PRECIS-2,"Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions.",fulltext,"Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions.",100.0
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,The study was conducted from February 2007 to March 2009.,fulltext,The study was conducted from February 2007 to March 2009.,100.0
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n  76) or to UC (n  74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n  76) or to UC (n  74).,100.0
675,PRECIS-2,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS 21 and 2) an Expanded Disability Status Scale (EDSS) 22 score of 6 (no to moderately severe disability), with 1 step increase within the last year.",fulltext,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS 21 and 2) an Expanded Disability Status Scale (EDSS) 22 score of 6 (no to moderately severe disability), with 1 step increase within the last year.",100.0
677,PRECIS-2,"The hypothesis is that the H-CAD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, TBI and MS patients when they are living at home.",fulltext,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",100.0
677,PRECIS-2,"Exclusions were: a) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; c) serious emotional problems; D) major visual problems; (e) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",fulltext,"exclusions were: a) disturbed upper limb function not related to MS, tBI or stroke; B) serious cognitive and/or behavioral problems; c) serious emotional problems; D) major visual problems; (e) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",100.0
677,PRECIS-2,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",fulltext,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,PRECIS-2,All measurements were performed at the centre where the patient had been treated.,fulltext,All measurements were performed at the centre where the patient had been treated.,100.0
677,PRECIS-2,The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group.,fulltext,the third measurement (t2) was performed after the month of H-caD intervention for the intervention group and 2 months after baseline for the control group.,100.0
677,PRECIS-2,"The subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or TBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",fulltext,"the subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",100.0
677,PRECIS-2,"The intervention group underwent one month of usual care, followed by approximately 4 training sessions with the H-CAD system in the hospital.",fulltext,"The intervention group underwent one month of usual care, followed by approximately 4 training sessions with the H-CAD system in the hospital.",100.0
677,PRECIS-2,"The main research question in this validation trial was: is the use of the H-CAD system for one month at least as good as usual care for the arm/hand function in stroke, TBI and MS patients?",fulltext,"lItAtIon clInIcAl trIAl was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",82.63157894736842
677,PRECIS-2,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",fulltext,"the tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (tBI), stroke or multiple sclerosis (MS).",100.0
677,PRECIS-2,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSc, Belgium).",fulltext,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSc, Belgium).",100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2,"Patients were randomized to receive a PCT immediately (fast track) or after a 12-week wait (usual best practice, control).",fulltext,"Patients were randomized to receive a PCT immediately (fast track) or after a 12-week wait (usual best practice, control).",100.0
678,PRECIS-2,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05e7.89) in the fast track compared to the control group.",fulltext,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05e7.89) in the fast track compared to the control group.",100.0
678,PRECIS-2,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,fulltext,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,100.0
678,PRECIS-2,"After initial assessment, treatment was recommended.",fulltext,"After initial assessment, treatment was recommended.",100.0
678,PRECIS-2,"The PCT comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext," PCT. 18,20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",98.49246231155779
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",fulltext,"We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",100.0
678,PRECIS-2,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital. The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",fulltext,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital. The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",100.0
679,PRECIS-2,"CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",97.83783783783784
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score �4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score �4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
679,PRECIS-2,"The intervention was delivered as planned in all patients except for two (2.5%) patients, who discontinued CDT prematurely.",fulltext," The intervention was delivered as planned in all patients except for two (2.5%) patients, who discontinued CDT prematurely",99.1869918699187
679,PRECIS-2,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).",fulltext,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional) ",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires.",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires ",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",100.0
680,PRECIS-2,The tailored early intervention is appropriate and clinically effective for the treatment of depressive symptoms in those newly diagnosed with MS.,fulltext,The tailored early intervention is appropriate and clinically effective for the treatment of depressive symptoms in those newly diagnosed with MS.,100.0
680,PRECIS-2,"To examine group differences at post and at 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the covariate.",fulltext,"ariables. To examine group differences at post and 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the ",93.29896907216495
680,PRECIS-2,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,"All participants completed the pre, post and 20 week follow up questionnaires.",fulltext,"All participants completed the pre, post and 20 week follow up questionnaires.",100.0
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive symptoms or anxiety for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,98.4536082474227
680,PRECIS-2,All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’.,fulltext,All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’.,100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms using the Beck Depression Inventory-II (BDI-II).,fulltext,The primary outcome was level of depressive symptoms using the Beck Depression Inventory-II (BDI-II).,100.0
680,PRECIS-2,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
681,PRECIS-2,"This study was undertaken in two community leisure setting, this is one of the first studies to utilise this format and, as there is a trend toward longer term rehabilitation and symptom management in the community in the UK, the results of this study are timely.",fulltext,"t study was undertaken in two community leisure setting, this is one of the first studies to utilise this format and, as there is a trend toward longer term rehabilitation and symptom management in the community in the UK, 30,31 the results of this study are timely.",98.85931558935361
681,PRECIS-2,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination and access to the intervention sites using their own or public transport.",fulltext,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale 33 score of 5 (ambulatory without aid or rest for 580 Clinical Rehabilitation 26(7) about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination 34 and access to the intervention sites using their own or public transport.",100.0
681,PRECIS-2,"The primary outcome measure was 25-foot (7.6 m) walk time, secondary outcomes assessed walking endurance, balance, physical function, leg strength, body mass index, activity levels, fatigue, anxiety and depression, quality of life and goal attainment.",fulltext,"The primary outcome measure was 25-foot (7.6 m) walk time, secondary outcomes assessed walking endurance, balance, physical function, leg strength, body mass index, activity levels, fatigue, anxiety and depression, quality of life and goal attainment.",100.0
681,PRECIS-2,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",fulltext,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",100.0
681,PRECIS-2,"Data were analysed using a univariate general linear model analysis of variance (ANOVA) which allowed for missing data, possible differences over time (baseline, week 8 and week 12) and possible differences between groups (intervention and control) to be assessed.",fulltext,"Data were Learmonth et al. 583 analysed using a univariate general linear model analysis of variance (ANOVA) which allowed for missing data, possible differences over time (baseline, week 8 and week 12) and possible differences between groups (intervention and control) to be assessed.",100.0
681,PRECIS-2,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,fulltext,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,100.0
681,PRECIS-2,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",fulltext,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",100.0
681,PRECIS-2,Attendance of participants at each class was recorded.,fulltext,Attendance of participants at each class was recorded.,100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",fulltext,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",100.0
681,PRECIS-2,"At week 8 three participants discontinued participation, with missing data for one other. At week 12 one other participant discontinued participation, with missing data for three other participants.",fulltext,"At week 8 three participants discontinued participation, with missing data for one other. At week 12 one other participant discontinued participation, with missing data for three other participants.",100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
681,PRECIS-2,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,fulltext,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,100.0
681,PRECIS-2,"Thus 32 people with multiple sclerosis, 23 female and nine male, participated in the study.",fulltext,"Thus 32 people with multiple sclerosis, 23 female and nine male, participated in the study.",100.0
681,PRECIS-2,"Including those who discontinued participation, the total attendance at the classes was 340 sessions out of a possible 480 (71%)",fulltext,"Including those who discontinued participation, the total attendance at the classes was 340 sessions out of a possible 480 (71%)",100.0
682,PRECIS-2,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor.",fulltext,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor.",100.0
682,PRECIS-2,"MSTEP©, a personally adapted exercise regimen done on most days including two days of high intensity exercise; guidelines recommending 30 minutes of moderate intensity aerobic and strength training two times per week.",fulltext,"MSTEP©, a personally adapted exercise regimen done on most days including two days of high intensity exercise; guidelines recommending 30 minutes of moderate intensity aerobic and strength training two times per week.",100.0
682,PRECIS-2,Participants in both groups received two private training sessions with the physical therapist or exercise therapist.,fulltext,Participants in both groups received two private training sessions with the physical therapist or exercise therapist.,100.0
682,PRECIS-2,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year.,fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed ,73.84615384615385
682,PRECIS-2,"Primary outcome was peak oxygen consumption (VO2peak) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",fulltext,"Primary outcome was peak oxygen consumption (VO 2peak ) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",100.0
682,PRECIS-2,"The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis. Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis. Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",100.0
682,PRECIS-2,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,fulltext,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,100.0
682,PRECIS-2,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",fulltext,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",100.0
682,PRECIS-2,"The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226) Recruitment commenced in March 2013 and the date of the last 12 month visit was March 2016.",fulltext,"The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226) Recruitment commenced in March 2013 and the date of the last 12 month visit was March 2016.",100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights.",100.0
684,PRECIS-2,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",fulltext,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",100.0
684,PRECIS-2,"Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",fulltext,"Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",100.0
684,PRECIS-2,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,100.0
684,PRECIS-2,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self-care functions and generally has effective use of arms).",fulltext,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many selfcare functions and generally has effective use of ",98.11320754716981
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",100.0
684,PRECIS-2,The programme was well tolerated with all 15 subjects in the treatment group completing the 8 week course and 92.5% of the session being delivered successfully.,fulltext, programme was well tolerated with all 15 subjects in the treatment group completing the 8 week course and 92.5% of the session being delivered successfully.,98.125
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,98.50746268656717
685,PRECIS-2,"Main outcome measures: These included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",fulltext,"Main outcome measures: These included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",100.0
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,PRECIS-2,"The statistical significance of the difference between scores was compared within and between control and intervention groups over time, in a two-factor, two-level, mixed design analysis of variance (ANOVA) or with nonparametric tests of significance, where appropriate.",fulltext,"The statistical signi cance of the difference between scores was compared within and between control and intervention groups over time, in a two-factor, two-level, mixed design analysis of variance (ANOVA) or with nonparametric tests of signi cance, where appropriate.",98.51851851851852
685,PRECIS-2,Follow-up assessments were conducted six months after baseline.,fulltext, assessments were conducted six months after baseline.,85.71428571428572
685,PRECIS-2,The intervention primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,fulltext, primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,90.41916167664671
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
685,PRECIS-2,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,fulltext,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"re 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inc",95.70552147239265
686,PRECIS-2,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic; and (ii) a standard care.",fulltext,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic; and (ii) a standard care.",100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,fulltext,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,100.0
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,Patients who were not living independently in the community were excluded.,fulltext,Patients who were not living independently in the community were excluded.,100.0
686,PRECIS-2,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsycholo",98.42696629213484
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,PRECIS-2,"The comparisons on the variation over six and 12 months of the MSIS-29 scale and secondary criteria (HAD scale, MFIS scale, QUALIVEEN and VAS) were analyzed in intention to treat with the Mann-Whitney test.",fulltext,"al variables. The comparisons on the variation over six and 12 months of the MSIS-29 scale and secondary criteria (HAD scale, MFIS scale, QUALIVEEN and VAS) were analyzed in intention to treat with the Mann-",93.68932038834951
686,PRECIS-2,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",fulltext,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",100.0
686,PRECIS-2,In most cases the same health professionals were in charge of the two groups.,fulltext,In most cases the same health professionals were in charge of the two groups.,100.0
687,PRECIS-2,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",fulltext,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, 13 stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",100.0
687,PRECIS-2,"For all outcome variables mean, standard deviation, mean difference and 95% confidence intervals and estimate of Cohen’s d effect size are reported.",fulltext,"For all outcome variables mean, standard deviation, mean difference and 95% confidence intervals and estimate of Cohen’s d effect size are reported.",100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",100.0
687,PRECIS-2,Twelve weeks of individualised web-based physiotherapy completed twice per week or usual care (control). Online exercise diaries were monitored; participants were telephoned weekly by the physiotherapist and exercise programmes altered remotely by the physiotherapist as required.,fulltext,Twelve weeks of individualised web-based physiotherapy completed twice per week or usual care (control). Online exercise diaries were monitored; participants were telephoned weekly by the physiotherapist and exercise programmes altered remotely by the physiotherapist as required.,100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,Setting: Rehabilitation centre and participants’ homes.,fulltext,Setting: Rehabilitation centre and participants’ homes.,100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
687,PRECIS-2,"The primary outcome measure, the timed 25ft walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
688,PRECIS-2,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.",fulltext,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis 17 and live in the ",88.53503184713377
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,fulltext,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,100.0
688,PRECIS-2,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.",100.0
688,PRECIS-2,Our objective in this randomised controlled trial was to compare health outcomes and cost-effectiveness between home based care and traditional hospital care delivered in a multiple sclerosis centre.,fulltext,Our objective in this randomised controlled trial was to compare health outcomes and cost-effectiveness between home based care and traditional hospital care delivered in a multiple sclerosis centre.,100.0
688,PRECIS-2,"The patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",fulltext,"The patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",100.0
688,PRECIS-2,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",100.0
688,PRECIS-2,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow up period were adjusted for the baseline values.",fulltext,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow up period were adjusted for the baseline values.",100.0
688,PRECIS-2,"A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",fulltext,"A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.",100.0
689,PRECIS-2,Seven Multiple Sclerosis outpatient centres across Scotland.,fulltext,Seven Multiple Sclerosis outpatient centres across Scotland.,100.0
689,PRECIS-2,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",100.0
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score which was administered at 12 months only.",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score 15 which was administered at 12 months only.",100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",100.0
689,PRECIS-2,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment), foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",fulltext,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment), 13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",100.0
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,"A repeated-measures analysis of variance (ANOVA) model was employed to analyse the outcome variables where the main factors, Group (ankle-foot orthoses/functional electrical stimulation), Time (Baseline (0), 3, 6, 12 months) and for the speed and oxygen cost of walking measures, the Condition (with/without device) and their interactions were applied.",fulltext,"A repeated-measures analysis of variance (ANOVA) model was employed to analyse the outcome variables where the main factors, Group (ankle-foot orthoses/functional electrical stimulation), Time (Baseline (0), 3, 6, 12 months) and for the speed and oxygen cost of walking measures, the Condition (with/without device) and their interactions were applied.",100.0
689,PRECIS-2,Subjects: Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,fulltext,Subjects: Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,100.0
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",100.0
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
690,PRECIS-2,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",fulltext,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",100.0
690,PRECIS-2,"Other patient inclusion criteria were primary or secondary progressive MS, Expanded Disability Status Scale (EDSS) score ⩾ 8.0, complex symptoms, and ⩾2 unmet care needs.",fulltext,"Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",100.0
690,PRECIS-2,Dyads were randomly assigned (2:1) to receive HPA or UC.,fulltext,Dyads were randomly assigned (2:1) to receive HPA or UC.,100.0
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"At each center, a multi-professional team delivered the 6-month intervention.",fulltext,"At each center, a multi-professional team delivered the 6-month intervention.",100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",100.0
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
690,PRECIS-2,"The team was not on call for dyads: in the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",fulltext,"The team was not on call for dyads: in the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",100.0
690,PRECIS-2,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",fulltext,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",100.0
690,PRECIS-2,Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers.,fulltext,Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers.,100.0
691,PRECIS-2,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",fulltext,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
691,PRECIS-2,"Primary outcomes were fatigue severity (Fatigue Assessment Instrument), self-efficacy (Multiple Sclerosis-Fatigue Self-Efficacy) and disease-specific quality of life (Multiple Sclerosis Impact Scale (MSIS-29)).",fulltext,"Primary outcomes were fatigue severity (Fatigue Assessment Instrument), self-efficacy (Multiple SclerosisFatigue Self-Efficacy) and disease-specific quality of life (Multiple Sclerosis Impact Scale (MSIS-29)) ",99.52380952380952
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,PRECIS-2,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,PRECIS-2,A total of 72 (86%) attended ≥ 4 sessions and 66 (79%) attended the final session.,fulltext,A total of 72 (86%) attended ≥ 4 sessions and 66 (79%) attended the final session.,100.0
691,PRECIS-2,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,fulltext,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,100.0
691,PRECIS-2,"The FACETS intervention uses health professionals routinely involved in managing MS, supported by a clinical psychologist.",fulltext,"The FACETS intervention uses health professionals routinely involved in managing MS, supported by a clinical psychologist.",100.0
692,PRECIS-2,"We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",fulltext,"We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",100.0
692,PRECIS-2,Participants were asked to listen to the prerecorded sessions and to follow the instructions.,fulltext,Participants were asked to listen to the prerecorded sessions and to follow the instructions.,100.0
692,PRECIS-2,We used non-parametric tests due to the small sample sizes which deviate from the normality and equal variance assumptions.,fulltext,We used non-parametric tests due to the small sample sizes which deviate from the normality and equal variance assumptions.,100.0
692,PRECIS-2,"MBI participants received daily mindfulness training in the form of prerecorded sessions (6 sessions of 10 min each equal to 1 h/day) using TailorBuilder application, aiming at developing awareness of emotions and sensations.",fulltext,"MBI participants received daily mindfulness training in the form of prerecorded sessions (6 sessions of 10 min each equal to 1 h/day) using TailorBuilder application, aiming at developing awareness of emotions and sensations.",100.0
692,PRECIS-2,Participants were able to modify their plans depending on their physical condition and availability.,fulltext,Participants were able to modify their plans depending on their physical condition and availability.,100.0
692,PRECIS-2,Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training.,fulltext,Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training.,100.0
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,Implementation Intention Participants were asked to develop a concrete if-then plan (the “if ” component followed by the “then” component) once a week and share them through TailorBuilder app.,fulltext,Implementation Intention Intention Implementation Participants were asked to develop a concrete if-then plan (the “if ” component followed by the “then” component) once a week and share them through TailorBuilder app.,100.0
692,PRECIS-2,Individuals participated in either a combination of PA and daily Mindfulness or a combination of PA and Implementation Intention.,fulltext,Individuals participated in either a combination of PA and daily Mindfulness or a combination of PA and Implementation Intention.,100.0
692,PRECIS-2,"The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",fulltext,"The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",100.0
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
693,PRECIS-2,Participants were randomly divided into SC and yoga group.,fulltext,Participants were randomly divided into SC and yoga group.,100.0
693,PRECIS-2,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90◦ and the height of 5 m was adjusted for patients with physical disabilities.",fulltext,"sions. SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90 ◦ and the height of 5 m was adjusted for patients with physical disabi",97.44525547445255
693,PRECIS-2,The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.,fulltext,venia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabi,95.59748427672956
693,PRECIS-2,Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
693,PRECIS-2,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",fulltext,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",100.0
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each p",95.48387096774194
693,PRECIS-2,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged.",99.62825278810409
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,"Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",fulltext,"Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",100.0
694,PRECIS-2,Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment.,fulltext, Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment,98.67549668874173
694,PRECIS-2,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,PRECIS-2,"The primary endpoint was the change in the Berg Balance Scale (BBS) after 12 weeks, and further outcome measures included fatigue, pain, quality of life, and spasticity.",fulltext," Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks, and further outcome measures included fatigue, pain, quality of life, and spasticity.",94.67455621301775
694,PRECIS-2,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,fulltext,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,100.0
694,PRECIS-2,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
695,PRECIS-2,"Participants were randomized to either the education group (EG) or the comparison group (CoG), within five diagnostic categories: MS, PD, Huntington's, motor neurone disease and other progressive neurological conditions.",fulltext,"participants were randomized to either the education group (EG) or the comparison group (CoG), within five diagnostic categories: MS, PD, Huntington's, motor neurone disease and other progressive neurological conditions.",100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,Primary outcome measures were reports of one or more falls or skin sores.,fulltext,Primary outcome measures were reports of one or more falls or skin sores.,100.0
695,PRECIS-2,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events (falls or sores) and for the five diagnostic categories.,fulltext,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events ,75.2212389380531
695,PRECIS-2,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK).",fulltext,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, ",97.31543624161074
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT.",fulltext,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT ",100.0
695,PRECIS-2,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",100.0
695,PRECIS-2,"Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language therapist, a physiotherapist, and a nurse.",fulltext,"Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language ",87.34939759036145
696,PRECIS-2,"Participants were randomised to either the immediate discontinuation group (IDG) or the tapered group (TG). IDG discontinued natalizumab at once and initiated another disease modifying therapy (DMT) following the last natalizumab infusion, while the TG received two more natalizumab infusions, at 6 and 8 weeks (14 weeks from study entry) before initiating another DMT.",fulltext,"Participants were randomised to either the immediate discontinuation group (IDG) or the tapered group (TG). IDG discontinued natalizumab at once and initiated another disease modifying therapy (DMT) following the last natalizumab infusion, while the TG received two more natalizumab infusions, at 6 and 8 weeks (14 weeks from study entry) before initiating another DMT.",100.0
696,PRECIS-2,"Statistical analyses were carried out using IBM SPSS Statistics 22 (IBM Corp, Armonk, New York, USA). Demographic characteristics of the TG versus IDG were compared using the χ2 test for nominal measures, Somers D for ordinal measures, and the student’s t test for differences in continuous measures.",fulltext,"es Statistical analyses were carried out using IBM SPSS Statistics 22 (IBM Corp, Armonk, New York, USA). Demographic characteristics of the TG versus IDG were compared using the χ 2 test for nominal measures, Somers D for ordinal measures, and the student’s t test for differences in continuous measu",98.66666666666667
696,PRECIS-2,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",fulltext,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",100.0
696,PRECIS-2,Discontinuation of participants from the allocated treatment or from the study was permitted as per patient request or treating physician decision.,fulltext,Discontinuation of participants from the allocated treatment or from the study was permitted as per patient request or treating physician decision.,100.0
696,PRECIS-2,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,fulltext,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,100.0
696,PRECIS-2,"Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT- fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs)",fulltext,"Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT- fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs)",100.0
696,PRECIS-2,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",100.0
696,PRECIS-2,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a tapered group (TG) approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,fulltext,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,94.83870967741936
696,PRECIS-2,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,fulltext,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,100.0
697,PRECIS-2,The group program was conducted at a local community center and included four to six participants per class.,fulltext,The group program was conducted at a local community center and included four to six participants per class.,100.0
697,PRECIS-2,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",82.36775818639799
697,PRECIS-2,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",100.0
697,PRECIS-2,"During the 8-week intervention, participants in the home group reported completing a lower proportion of exercise sessions than those in the group exercise program (mean percentage of sessions completed 45% versus 83% P < .001).",fulltext," During the 8-week intervention, participants in the home group reported completing a lower proportion of exercise sessions than those in the group exercise program (mean percentage of sessions completed 45% versus 83% P < .001)",99.56140350877193
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test).,fulltext,The primary outcome was gait speed (10-meter walk test).,100.0
697,PRECIS-2,"Exercises were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"ey were individualized, specific, progressed in load, and performed at a moderate to high intensity.",92.5233644859813
697,PRECIS-2,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,PRECIS-2,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle.,fulltext, Data were analyzed according to the intention-totreat principle,96.92307692307692
697,PRECIS-2,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",fulltext,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",100.0
697,PRECIS-2,"Participants were assessed at two points at baseline (8 weeks apart) to establish stability of presentation, at the end of an 8-week training period and at 8-week follow-up.",fulltext,"Participants were assessed at two points at baseline (8 weeks apart) to establish stability of presentation, at the end of an 8-week training period and at 8-week follow-up.",100.0
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",100.0
705,PRECIS-2,"Program sessions com- prised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",99.45799457994579
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,"The Hockey FIT pro- gram was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.",fulltext,"The Hockey FIT pro- gram was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.",100.0
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",100.0
705,PRECIS-2,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,100.0
705,PRECIS-2,"In addition to the weekly in-person sessions, participants took part in an incremental pedometer-based walking program and they both set and tracked lifestyle prescriptions for PA (steps), exercise, and healthy eating.",fulltext,"In addition to the weekly in-person sessions, participants took part in an incremental pedometer-based walking program and they both set and tracked lifestyle prescriptions for PA (steps), exercise, and healthy eating.",100.0
705,PRECIS-2,"Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",100.0
705,PRECIS-2,"At baseline, groups were balanced on most demographic and health history characteristics, as well as study outcomes.",fulltext,"At baseline, groups were balanced on most demographic and health history characteristics, as well as study outcomes.",100.0
705,PRECIS-2,"Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",fulltext," 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",88.88888888888889
705,PRECIS-2,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",fulltext,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",100.0
705,PRECIS-2,"For the remaining 30 men (i.e., program completers), the mean (SD) for percentage of sessions attended was 81.7% (13.7).",fulltext,"For the remaining 30 men (i.e., program completers), the mean (SD) for percentage of sessions attended was 81.7% (13.7).",100.0
712,PRECIS-2,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition. Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",fulltext,"We included expectant mothers of different ages and states from the 37th week in where child birth was expected any time (induced or conduced) having: dilations at ≥ 4 cm, two or more contractions in 10 minutes, skin covering the whole of the SP6 bilateral point and with a live fetus with a cephalic vertex and in good condition. Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",100.0
712,PRECIS-2,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups at a university hospital in the suburbs of Sao Paulo, Brazil.",fulltext,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups:,75.69721115537848
712,PRECIS-2,The purpose of this study was to analyze the effects of acupressure on the SP6 point for the pain in child birth for expectant mothers in public maternity units.,fulltext,The purpose of this study was to analyze the effects of acupressure on the SP6 point for the pain in child birth for expectant mothers in public maternity units.,100.0
712,PRECIS-2,All of the pregnant women in labor where encouraged during the CB to breath in and out deeply in the direction of the thorax during the contractions and the intervals in orde for their bodies to be totally relaxed (slow thorax-abdomen breathing rhythm).,fulltext,All of the pregnant women in labor where encouraged during the CB to breath in and out deeply in the direction of the thorax during the contractions and the intervals in orde for their bodies to be totally relaxed (slow thorax-abdomen breathing rhythm).,100.0
712,PRECIS-2,"Information in relation to the use of medication and anesthesia was registered in accordance with the relevant procedures and were checked by a team of professionals at the institution. They looked at inpatient records, forms containing the use of anesthesia, partograms and medical prescriptions.",fulltext,"Information in relation to the use of medication and anesthesia was registered in accordance with the relevant procedures and were checked by a team of professionals at the institution. They looked at inpatient records, forms containing the use of anesthesia, partograms and medical prescriptions.",100.0
712,PRECIS-2,The Kruskal-Wallis test was used to make comparisons between the groups in relation to quantitative variables. The Mann-Whitney test was used in cases where significant differences were found for multiple comparisons.,fulltext,The Kruskal-Wallis test was used to make comparisons between the groups in relation to quantitative variables. The Mann-Whitney test was used in cases where significant differences were found for multiple comparisons.,100.0
712,PRECIS-2,"The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",fulltext,"The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",100.0
712,PRECIS-2,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g). In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",fulltext,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g) (15) . In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",100.0
713,PRECIS-2,The main approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,fulltext,The main approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,100.0
713,PRECIS-2,"Data were collected at months zero, six and 12.",fulltext,"Data were collected at months zero, six and 12.",100.0
713,PRECIS-2,The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed.,fulltext,The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed.,100.0
713,PRECIS-2,The group (intervention) 9 time interaction from a repeated analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximately normal distribution.,fulltext,The group (intervention) 9 time interaction from a repeated analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximately normal distribution ,100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,Inclusion criteria were patients aged 45-65 with mild and moderate chronic obstructive pulmonary disease (grade II and III) as the primary disease. No criteria were set for family members accompanying the patients.,fulltext,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease. No criteria were set for family members accompanying the patients.,84.57943925233646
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
713,PRECIS-2,"Experimental group (n = 48) participated in a 6-month, partnership-based self-management programme consisting of: (a) three to four conversations between nurse and patient-family member; (b) 6 months of smoking cessation; and (c) interdisciplinary team-patient-family member group meeting.",fulltext,"Experimental group (n = 48) participated in a 6-month, partnership-based self-management programme consisting of: (a) three to four conversations between nurse and patient-family member; (b) 6 months of smoking cessation; and (c) interdisciplinary team-patient-family member group meeting.",100.0
713,PRECIS-2,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,fulltext,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,100.0
714,PRECIS-2,Patients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.,fulltext,Patients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.,100.0
714,PRECIS-2,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary. Patients were free to arrange any consultations they wished.,fulltext,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary. Patients were free to arrange any consultations they wished.,100.0
714,PRECIS-2,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,PRECIS-2,"Primary outcome measures were the proportion of patients reviewed within three months of randomisation and disease-specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",99.52380952380952
714,PRECIS-2,Four general practices in England.,fulltext,Four general practices in England.,100.0
714,PRECIS-2,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,PRECIS-2,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,fulltext,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,100.0
714,PRECIS-2,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm.",fulltext,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm ",100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previDepartment,67.36401673640167
715,PRECIS-2,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",fulltext,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",100.0
715,PRECIS-2,The primary endpoint shows that NLC was not inferior to RLC at any follow-up time point.,fulltext,The primary endpoint shows that NLC was not inferior to RLC at any follow-up time point.,100.0
715,PRECIS-2,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52.",fulltext,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52.",100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), age 18 years or older and the ability to complete questionnaires unaided.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided.",100.0
715,PRECIS-2,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,100.0
715,PRECIS-2,"Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,PRECIS-2,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",fulltext,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",100.0
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",100.0
722,PRECIS-2,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
722,PRECIS-2,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between January 2010 and May 2012.,fulltext,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between 9,79.52755905511812
722,PRECIS-2,"Primary outcomes were self-reported combination treatment use, systolic blood pressure and total cholesterol.",fulltext,"Primary outcomes were self-reported combination treatment use, systolic blood pressure and total cholesterol.",100.0
722,PRECIS-2,"Participants had established CVD or an estimated five-year CVD risk of 15%, with indications for antiplatelet, statin and 2 blood pressure lowering drugs (‘combination treatment’). Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg.",fulltext,"Participants had established CVD or an estimated five-year CVD risk of 15%, with indications for antiplatelet, statin and 2 blood pressure lowering drugs (‘combination treatment’). Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg.",100.0
722,PRECIS-2,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,fulltext,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,100.0
722,PRECIS-2,All participants were treated by their regular doctor following randomization. No attempt was made to influence the management of usual care participants.,fulltext,All participants were treated by their regular doctor following randomization. No attempt was made to influence the management of usual care participants.,100.0
725,PRECIS-2,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",fulltext,"Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.",100.0
725,PRECIS-2,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,fulltext,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,100.0
725,PRECIS-2,"Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both groups.",fulltext,". Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both group",99.1769547325103
725,PRECIS-2,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,fulltext,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,100.0
725,PRECIS-2,"To avoid learning curve problems, surgeons and physiotherapists used surgical interventions and procedures with which they were familiar.",fulltext,"To avoid learning curve problems, surgeons and physiotherapists used surgical interventions and procedures with which they were familiar.",100.0
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
725,PRECIS-2,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data. The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,fulltext,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data. The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,100.0
725,PRECIS-2,"Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.",fulltext,"Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.",100.0
725,PRECIS-2,"Participants allocated to surgery received either internal fracture fixation (eg, with plate and screws) that preserved the humeral head or humeral head replacement (hemiarthroplasty). Participants allocated to nonsurgical treatment were given a sling for the injured arm for as long as deemed necessary (3 weeks was suggested), followed by active rehabilitation.",fulltext,"Participants allocated to surgery received either internal fracture fixation (eg, with plate and screws) that preserved the humeral head or humeral head replacement (hemiarthroplasty). Participants allocated to nonsurgical treatment were given a sling for the injured arm for as long as deemed necessary (3 weeks was suggested), followed by active rehabilitation.",100.0
725,PRECIS-2,"Patients received their allocated treatment from the recruiting hospital. Care pathways for all patients included outpatient- and community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",fulltext,"Patients received their allocated treatment from the recruiting hospital. Care pathways for all patients included outpatientand community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",99.26470588235294
733,PRECIS-2,"The interventions were the home-based Otago Exercise Programme (OEP), and a group-based exercise programme called Falls Management Exercise (FaME).",fulltext," Otago Exercise Programme (OEP), 10 and a group-based exercise programme called Falls Management Exercise (FaME).",74.82993197278911
733,PRECIS-2,"Attempts were made to exclude those who were already exercising at, or above, the target level through a pre-assessment screening telephone call.",fulltext,"Attempts were made to exclude those who were already exercising at, or above, the target level through a pre-assessment screening telephone call.",100.0
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,100.0
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",100.0
733,PRECIS-2,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,fulltext,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
733,PRECIS-2,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",fulltext,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",100.0
733,PRECIS-2,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",fulltext,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,fulltext,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,100.0
733,PRECIS-2,"Falls were ascertained from diaries returned by participants every 4 weeks during the intervention and every 3 months in the subsequent year, and from reports given in follow-up telephone interviews using the Phone-FITT questionnaire.",fulltext,"Falls were ascertained from diaries returned by participants every 4 weeks during the intervention and every 3 months in the subsequent year, and from reports given in follow-up telephone interviews using the Phone-FITT questionnaire.",100.0
733,PRECIS-2,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise.,fulltext,Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,100.0
733,PRECIS-2,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",100.0
